Evidence map›Paper›PMID 24082331›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2012

Proapoptotic, anti-cell proliferative, anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

Duraisamy Rajasekaran, Shanmugam Manoharan, Simon Silvan, Krishnamoorthy Vasudevan, Nagarethinam Baskaran, Duraisamy Palanimuthu

Open access · diamondAbstract read
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Molecules (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Anticancer Activity ofNutrients · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Duraisamy RajasekaranDepartment of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar - 608 002.
Shanmugam Manoharan
Simon Silvan
Krishnamoorthy Vasudevan
Nagarethinam Baskaran
Duraisamy Palanimuthu
Annamalai University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study has investigated the modulating effect of carnosic acid on the expression pattern of cell proliferative (proliferating cell nuclear antigen (PCNA) cyclin D1 and a transcription factor c-fos), apoptotic (p53, Bcl-2, Bax caspase -3 and 9), inflammatory (Nuclear factor kappa B (NFκB) and cyclooxygenase-2 (COX- 2) and angiogenic (vascular endothelial growth factor (VEGF) markers during 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. Oral tumors were developed in the hamsters buccal pouches by painting with 0.5% DMBA in liquid paraffin three times a week for 14 weeks. Hundred per cent tumour formation (well-differentiated squamous cell carcinoma) accompanied by deregulation in the above mentioned molecular markers was noticed in hamsters treated with DMBA alone (tumour bearing hamsters). Oral administration of carnosic acid at dose of 10mg/kg bw to hamsters treated with DMBA not only completely prevented the tumour formation, but also corrected the abnormalities in the expression pattern of molecular markers. The present study suggests that carnosic acid might have inhibited the tumour formation by exerting anti-cell-proliferative, anti-inflammatory, anti-angiogenic and apoptotic potential during DMBA-induced hamster buccal pouch carcinogenesis.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAbietanesAngiogenesis InhibitorsAnimalsAnticarcinogenic AgentsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicApoptosisBiomarkersCarcinogenesisCarcinoma, Squamous CellCell ProliferationCyclin D1Inflammation MediatorsMaleMesocricetus9,10-Dimethyl-1,2-benzanthraceneAbietanesAngiogenesis InhibitorsAnticarcinogenic AgentsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicBiomarkersCyclin D1Inflammation MediatorsPlant ExtractsProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-fossalvinVascular Endothelial Growth Factor Aangiogenesisapoptosiscell proliferationinflammationoral cancer

Identifiers

PMID24082331
PMCPMC3746363
OpenAlexW1983701394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.